Indirect comparison of lixisenatide versus neutral protamine Hagedorn insulin as add-on to metformin and sulphonylurea in patients with type 2 diabetes mellitus

Objective: There is currently a lack of evidence from direct comparisons of treatment outcomes with lixisenatide versus neutral protamine Hagedorn (NPH)-insulin in type 2 diabetes mellitus (T2DM) patients with suboptimal glycaemic control with oral antidiabetic drugs (OADs). Hence, the current analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Fournier, Marie, Germe, Maeva, Theobald, Karlheinz, Scholz, Gerhard H., Lehmacher, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202665/
https://www.ncbi.nlm.nih.gov/pubmed/25332702
http://dx.doi.org/10.3205/000199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202665/
https://www.ncbi.nlm.nih.gov/pubmed/25332702
http://dx.doi.org/10.3205/000199

Ejemplares similares